| 2002 |
SERA3 (PF3D7_0207800) gene could be disrupted in P. falciparum blood-stage parasites without loss of viability, demonstrating it is dispensable for erythrocytic cycle maintenance. Additionally, antibodies from malaria-immune individuals reacted with SERA3 recombinant protein, suggesting expression in at least some parasite populations. |
Gene disruption (knockout) by targeted homologous recombination; reactivity with immune sera |
The Journal of biological chemistry |
Medium |
12228245
|
| 2002 |
Polyclonal antibodies against the N-terminal recombinant domain of SERA3 detected SERA3 protein expression by indirect immunofluorescence microscopy in trophozoite- and schizont-infected erythrocytes, with localization similar to other SERA family members (SERA4–6). |
Indirect immunofluorescence microscopy with specific polyclonal antibodies against SERA3 N-terminal recombinant protein |
The Journal of biological chemistry |
Medium |
12244052
|
| 1994 |
SERA3 was identified as a distinct gene located 1.8 kb upstream of the SERA (SERA5) gene on chromosome 2, transcribed in the same orientation. SERA3 mRNA is expressed in a stage-specific manner, exclusively in trophozoite and schizont stages, as part of a coordinately regulated transcription cluster with SERA and SERA2. |
RT-PCR, transcript mapping, RNA sequencing, Northern analysis |
Molecular and biochemical parasitology |
Medium |
7891737
|
| 2007 |
SERA3 (PF3D7_0207800) belongs to the serine-type SERA subgroup in P. falciparum, possessing an atypical active-site serine residue instead of the canonical cysteine in its papain-like protease domain. Knockout of SERA3 (along with SERA1, SERA4, SERA9) was achievable, confirming it is non-essential for blood-stage survival, in contrast to SERA5 which could not be disrupted. |
Targeted gene knockout by homologous recombination; phylogenetic analysis of active-site residues |
Infection and immunity |
Medium |
17893128
|
| 2008 |
P. berghei SERA3 (PbSERA3), the ortholog studied in a rodent malaria model, is transcribed in late liver stages and its protein is processed and detected by Western blot in schizont-infected cells and merozoite-infected detached hepatic cells. Immunofluorescence assays showed PbSERA3 leaks into the host cell cytoplasm during merozoite development in hepatocytes, potentially contributing to host cell death or activating host cell proteases. |
RT-PCR, transgenic P. berghei expressing TAP-tagged PbSERA3 under endogenous promoter, immunofluorescence assay, Western blot |
Cellular microbiology |
Medium |
18419771
|
| 2009 |
In P. berghei, deletion of the serine-type SERAs (PbSERA1 and PbSERA2, the serine-type subfamily members) resulted in increased expression of the cysteine-type PbSERA3, indicating compensatory upregulation between SERA subfamilies. P. berghei serine-type SERA knockouts progressed normally through the parasite life cycle, further supporting non-essential roles for serine-type SERAs when cysteine-type members can compensate. |
Single and double gene knockouts by targeted gene replacement; fluorescent tagging with mCherry for localization; antibody localization; expression analysis |
Cellular microbiology |
Medium |
20039882
|
| 2019 |
PbSERA3 (the P. berghei ortholog) is expressed in gametocytes and is processed by the subtilisin-like serine protease PbSUB1 upon gametocyte activation, establishing PbSERA3 as a substrate of PbSUB1 in sexual stages. |
Transgenic P. berghei lines deficient in PbSUB1 expression or enzyme activity; Western blot detection of PbSERA3 processing products |
Cellular microbiology |
Medium |
30941868
|
| 2026 |
PbSERA3 is required for hepatic merozoite egress in P. berghei. Conditional mutants (Flp/FRT system) developed normally through late liver stages but failed to initiate blood-stage infection, demonstrating a specific role in egress from hepatocytes. PbSERA3 was also found on the surface of ookinetes and sporozoites under non-permeabilized conditions (extracellular localization), and is processed in these stages into two products as in blood stages. PbSERA3 is identified as a substrate of SUB1, and its proteolytic maturation by SUB1 is implicated as a conserved and critical event for hepatic egress. |
Yeast-based Flp/FRT conditional mutagenesis; surface labeling under non-permeabilized conditions; Western blot for processing products; transgenic parasite lines |
mBio |
High |
41616267
|